Adults with Prader–Willi Syndrome have Weaker Bones: Effect of Treatment with GH and Sex Steroids

Calcified Tissue International

Volumn 96, Issue 2, 2015, Pages 160-166

  Longhi, Silvia ^a   Grugni, Graziano ^b   Gatti, Davide ^c   Spinozzi, Emiliano ^b   Sartorio, Alessandro ^b   Adami, Silvano ^c   Fanolla, Antonio ^a   Radetti, Giorgio ^a  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Bone density; Bone geometry; Obesity; Prader Willi syndrome

Indexed keywords

GROWTH HORMONE; SEX HORMONE;

ADULT; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE STRENGTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; CROSS-SECTIONAL STUDY; FEMALE; GEOMETRY; HORMONAL THERAPY; HUMAN; MALE; METACARPAL BONE; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; THERAPY EFFECT; X RAY; ADOLESCENT; BONE; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRADER-WILLI SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; GONADAL STEROID HORMONES; GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; OBESITY; PRADER-WILLI SYNDROME; YOUNG ADULT;

EID: 84922287210     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-014-9949-1     Document Type: Article

References (36)

1. Bakker I, Twisk JW, Van Mechelen W, Kemper HC (2003) Fat-free body mass is the most important body composition determinant of 10-yr longitudinal development of lumbar bone in adult men and women. J Clin Endocrinol Metab 88:2607–2613
2. Taes YE, Lapauw B, Vanbillemont G et al (2009) Fat mass is negatively associated with cortical bone size in young healthy male siblings. J Clin Endocrinol Metab 94:2325–2331
3. Hsu YH, Venners SA, Terwedow HA et al (2006) Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 83:146–154
4. Rocher E, Chappard C, Jaffre C, Benhamou CL, Courteix D (2008) Bone mineral density in prepubertal obese and control children: relation to body weight, lean mass, and fat mass. J Bone Miner Metab 26:73–78
5. Ng AC, Melton LJ 3rd, Atkinson EJ et al (2013) Relationship of adiposity to bone volumetric density and microstructure in men and women across the adult lifespan. Bone 55:119–125
6. Longhi S, Pasquino B, Calcagno A et al (2013) Small metacarpal bones of low quality in obese children. Clin Endocrinol (Oxf) 78:79–85
7. Butler MG (2011) rader-Willi syndrome: obesity due to genomic imprinting. Curr Genomics 12:204–215
8. Goldstone AP (2004) Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 15:12–20
9. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14:10–26
10. Theodoro MF, Talebizadeh Z, Butler MG (2006) Body composition and fatness patterns in Prader- Willi syndrome: comparison with simple obesity. Obesity 14:1685–1690
11. Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG (2006) Circulating adiponectin levels, body composition, and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes 30:382–387
12. Goldstone AP, Thomas EL, Brynes AE et al (2001) isceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 86:4330–4338
13. Talebizadeh Z, Butler M (2005) Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet 67:230–239
14. Van Mil EG, Westerterp KR, Gerver WJ, Van Marken Lichtenbelt WD, Kester AD, Saris WH (2001) Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: relationship to physical activity and growth hormone function. J Pediatr 139:708–714
15. Reus L, van Vlimmeren LA, Staal JB, Otten BJ, Nijhuis-van der Sanden MW (2012) The effect of growth hormone treatment or physical training on motor performance in Prader-Willi syndrome: A systematic review. Neurosci Biobehav Rev 36:1817–1838
16. Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID (2001) Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet 103:216–222
17. Vestergaard P, Kristensen K, Bruun JM et al (2004) Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index—a cross-sectional study. J Pediatr 144:614–619
18. Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB (2010) Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome. J Clin Endocrinol Metab 95:1131–1136
19. Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS (2013) Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 98:E1072–E1087
20. Kroonen LT, Herman M, Pizzutillo PD, Macewen GD (2006) Prader-Willi Syndrome: clinical concerns for the orthopaedic surgeon. J Pediatr Orthop 26:673–679
21. Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HM et al (2011) Physical health problems in adults with Prader-Willi syndrome. Am J Med Genet A 155:2112–2124
22. Carrel AL, Myers SE, Whitman BY, Allen DB (2002) Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab 87:1581–1585
23. Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB (2010) Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome. J Clin Endocrinol Metab 95:1131–1136
24. Zamberlan N, Radetti G, Paganini C et al (1996) Evaluation of cortical thickness and bone density by roentgen microdensitometry in growing males and females. Eur J Pediatr 155:377–382
25. Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14:595–608
26. Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T (2002) Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol 44:248–255
27. Mackie EJ, Tatarczuch L, Mirams M (2011) The growth plate chondrocyte and endochondral ossification. J Endocrinol 211:109–121
28. Ohlsson C, Mohan S, Sjogren K et al (2009) The role of liver-derived insulin-like growth factor-I. Endocr Rev 30:494–535
29. Olson LE, Ohlsson C, Mohan S (2011) The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice. Calcif Tissue Int 88:1–8
30. Walenkamp MJ, Wit JM (2007) Genetic disorders in the GH IGF-I axis in mouse and man. Eur J Endocrinol 157:S15–S26
31. Yakar S, Courtland HW, Clemmons D (2010) IGF-1 and bone: new discoveries from mouse models. J Bone Miner Res 25:2543–2552
32. Mohan S, Baylink DJ (1999) Role of growth hormone/insulin-like growth factor axis. In: Glowacki J, Rosen CJ, Bilezikian JP (eds) The aging skeleton. Academic, San Diego, pp 209–219
33. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19:55–79
34. Boonchaya-Anant P, Holick MF, Apovian CM (2014) Serum 25-hydroxyvitamin D levels and metabolic health status in extremely obese individuals. Obesity (Silver Spring) 22:2539–2543
35. Högler W, Shaw N (2010) Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clin Endocrinol 72:281–289
36. Jørgensen AP, Ueland T, Sode-Carlsen R et al (2013) Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD. J Clin Endocrinol Metab 98:E753–E760